8
września

2017 ASH Meeting on Hematologic Malignancies

rok: 2017 czas trwania: 1 dni zakończenie: 2017-09-09

Join us in Chicago for the 2017 ASH Meeting on Hematologic Malignancies and gain knowledge that can help you make an immediate impact on your practice. The meeting will feature the top experts in the field, comprehensive clinical content, the latest clinical research, and opportunities to interact with colleagues in an intimate, small-group setting with no competing sessions.

MHM17_vid

The program content will be structured as "How I Treat" presentations which will showcase each speaker's evidence-based treatment approaches, present cutting-edge scientific data that can be translated into new strategies for diagnosis and treatment, and address what to do in cases where there is no data. Experts will provide out-of-the-box treatment approaches, answer challenging patient care questions during topic-based panel discussions, and engage in stimulating conversations on specific disease topics during Lunch with the Experts sessions.

View Session Previews

Get a sneak peek at topics to be discussed during the 2017 meeting, including exciting updates in each of the core malignancies.

  • Leukemia
  • Lymphoma
  • Myelodysplastic syndromes
  • Myeloma
  • Myeloproliferative neoplasms

Key Date

Late/On-Site registration opens September 7, 2017

Program Co-Chairs

Jonathan W. Friedberg, MD

Jonathan W. Friedberg, MD
University of Rochester

Ruben A. Mesa, MD

Ruben A. Mesa, MD
Mayo Clinic

Wendy Stock, MD

Wendy Stock, MD
University of Chicago

Program Planning Committee

  • Anjali Advani, MD, Cleveland Clinic
  • Jonathan W. Friedberg, MD, University of Rochester
  • John P. Leonard, MD, Weill Cornell Medical College
  • Ruben A. Mesa, MD, Mayo Clinic
  • Vincent Rajkumar, MD, Mayo Clinic
  • David Steensma, MD, Dana-Farber Cancer Institute
  • Wendy Stock, MD, University of Chicago 

ikona Info OFICJALNA STRONA WYDARZENIA

Wróć do kalendarza
kodowanie: projekt: